World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
22799
World Ranking
18032
National Ranking
8988

Overview

Alan Forrest is affiliated with the University at Buffalo, State University of New York in the United States. Their research primarily spans the fields of Biochemistry, Genetics and Molecular Biology, with 42 publications, and Medicine, with 41 publications. Subfields within these areas include Molecular Medicine, Molecular Biology, Pharmacology, Oncology, and Public Health, Environmental and Occupational Health.

Forrest's topics of work cover various aspects of biomedical science, including:

  • Antibiotic Resistance in Bacteria
  • Antibiotics Pharmacokinetics and Efficacy
  • Malaria Research and Control
  • Cancer therapeutics and mechanisms
  • Vibrio bacteria research studies
  • Lung Cancer Research Studies
  • Genetic diversity and population structure

The scientist has contributed to multiple recent papers in diverse publication venues. Selected recent papers include:

  • "Global Brassicaceae phylogeny based on filtering of 1,000-gene dataset," 2023, published in Current Biology
  • "What We Know and What We Do Not Know about Dragon Trees?", 2020, published in Forests
  • "Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii," 2020, Clinical Microbiology and Infection
  • "Ecological and geological processes impacting speciation modes drive the formation of wide-range disjunctions within tribe Putorieae (Rubiaceae)," 2021, Journal of Systematics and Evolution
  • "Cost-effectiveness analysis of forest ecosystem services in mountain areas in Afghanistan," 2021, Land Use Policy

Frequent publication venues for Forrest include UNC Libraries with 21 publications, Clinical Microbiology and Infection with 2, and single contributions to Current Biology, Forests, and Journal of Systematics and Evolution.

Typical collaboration partners for Forrest are notable researchers including Jian Li (17 co-authored papers), Brian T. Tsuji (15), Roger L. Nation (14), Jürgen B. Bulitta (12), and Patricia N. Holden (9).

Best Publications

  • Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients.

    A Forrest;D E Nix;C H Ballow;T F Goss

  • Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia

    George Sakoulas;Pamela A. Moise-Broder;Jerome Schentag;Alan Forrest

  • International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti-infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP).

    Brian T. Tsuji;Jason M. Pogue;Alexandre P. Zavascki;Mical Paul;Mical Paul

  • Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients

    Samira Garonzik;Jian Li;Jian Li;Visanu Thamlikitkul;David Paterson

  • Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections

    Pamela A. Moise-Broder;Alan Forrest;Mary C. Birmingham;Jerome J. Schentag

  • Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

    Paul G. Ambrose;Sujata M. Bhavnani;Christopher M. Rubino;Arnold Louie

  • Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

    Jennifer K. Thomas;Alan Forrest;Sujata M. Bhavnani;Judith M. Hyatt

  • Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing.

    Lauren M Lim;Neang S Ly;Dana Anderson;Jenny C Yang

  • Population Pharmacokinetics of Intravenous Polymyxin B in Critically Ill Patients: Implications for Selection of Dosage Regimens

    Ana M Sandri;Cornelia Barbara Landersdorfer;Cornelia Barbara Landersdorfer;Jovan Jacob;Marcio M Boniatti

  • Accessory Gene Regulator Group II Polymorphism in Methicillin-Resistant Staphylococcus aureus Is Predictive of Failure of Vancomycin Therapy

    Pamela A. Moise-Broder;George Sakoulas;George M. Eliopoulos;Jerome J. Schentag

  • Clinical Pharmacodynamics of Linezolid in Seriously Ill Patients Treated in a Compassionate Use Programme

    Craig R Rayner;Alan Forrest;Alison K Meagher;Mary C Birmingham

  • Vancomycin in vitro bactericidal activity and its relationship to efficacy in clearance of methicillin-resistant Staphylococcus aureus Bacteremia

    Pamela A. Moise;George Sakoulas;Alan Forrest;Jerome J. Schentag

  • Dosing guidance for intravenous colistin in critically-ill patients.

    Roger L. Nation;Samira M. Garonzik;Visanu Thamlikitkul;Evangelos J. Giamarellos-Bourboulis

  • Prospective validation of a pharmacologically based dosing scheme for the cis-diamminedichloroplatinum(II) analogue diamminecyclobutanedicarboxylatoplatinum.

    M. J. Egorin;D. A. Van Echo;E. A. Olman;M. Y. Whitacre

  • Phase I and II Study of the Safety, Virologic Effect, and Pharmacokinetics/Pharmacodynamics of Single-Dose 3-O-(3′,3′-Dimethylsuccinyl)Betulinic Acid (Bevirimat) against Human Immunodeficiency Virus Infection

    Patrick F. Smith;Patrick F. Smith;Abayomi Ogundele;Abayomi Ogundele;Alan Forrest;John Wilton

  • Area under the inhibitory curve and a pneumonia scoring system for predicting outcomes of vancomycin therapy for respiratory infections by Staphylococcus aureus

    Pamela A. Moise;Alan Forrest;Sujata M. Bhavnani;Mary C. Birmingham

  • Pharmacokinetic/Pharmacodynamic Investigation of Colistin against Pseudomonas aeruginosa Using an In Vitro Model

    Phillip John Bergen;Jurgen B Bulitta;Alan Forrest;Brian Tsuji

  • Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers

    Aileen Bown Luzier;Aaron Killian;John H. Wilton;Michael F. Wilson

  • Population Pharmacokinetics of Linezolid in Patients Treated in a Compassionate-Use Program

    Alison K. Meagher;Alan Forrest;Craig R. Rayner;Mary C. Birmingham

  • Updated US and European Dose Recommendations for Intravenous Colistin: How Do They Perform?

    Roger L. Nation;Samira M. Garonzik;Jian Li;Visanu Thamlikitkul

Frequent Co-Authors

Brian T. Tsuji
Brian T. Tsuji University at Buffalo, State University of New York
Jürgen B. Bulitta
Jürgen B. Bulitta St. Jude Children's Research Hospital
Sujata M. Bhavnani
Sujata M. Bhavnani University at Buffalo, State University of New York
Jerome J. Schentag
Jerome J. Schentag University at Buffalo, State University of New York
Roger L. Nation
Roger L. Nation Monash University
David L. Paterson
David L. Paterson University of Queensland
Margaret A. Fischl
Margaret A. Fischl University of Miami
Tony Velkov
Tony Velkov University of Melbourne
Ronald N. Jones
Ronald N. Jones JMI Laboratories
George Sakoulas
George Sakoulas University of California, San Diego

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in medicine, there are many alternative and complementary pathways to consider beyond traditional MD programs. Online education has made it easier to start or advance your healthcare career while balancing other life commitments.

If you’re already an RN looking to expand your qualifications, explore the cheapest accredited online rn to bsn programs to earn your BSN affordably and flexibly. For those aiming for leadership or research roles, online phd programs in nursing offer advanced training without requiring relocation or a career break.

Even students without a nursing background can break into the field with online msn programs for non nurses, which allow non-nursing graduates to earn a master’s degree in nursing efficiently. If you are looking for more accessible entry points, research nursing programs with high acceptance rates to find the right fit for your goals.

Online programs provide flexible learning, diverse specialization options, and cost-effective alternatives, making a career in healthcare more accessible than ever.

Best Scientists Citing Alan Forrest

Trending Scientists

Recently Published Articles